{"cluster": 43, "subcluster": 0, "abstract_summ": "Majority of lesions were localized on the trunk (66.7%, 50/72), however, 19.4% (14/72) of patients experienced cutaneous manifestations in the hands and feet.Although larger prospective studies are needed, current evidence indicates that acral skin lesions should not be regarded as a sign of COVID\u201019 in otherwise asymptomatic patients.Recently, young COVID\u201019 patients have presented with erythematous and purpuric acral lesions similar to chilblains(1\u20133).To establish the real prevalence of COVID\u201019 in patients with acral skin lesions, we firstly evaluated all the cases of acral lesions presented in dermatology and paediatrics departments and family doctors\u2019 offices in an eastern Spanish region over a three\u2010week period.In this work, we aimed to analyze our experience in a French referral center and to perform a systematic review of the literature to evaluate the incidence and prognosis of cutaneous lesions observed in COVID-19 patients.", "title_summ": "A prospective study and literature reviewPatients with specific skin disorders who are affected by COVID\u201019: what do experiences say about management strategies? : A systematic reviewSARS\u2010CoV\u20102, skin lesions and the need of a multidisciplinary approachCutaneous manifestations of COVID-19: Report of three cases and a review of literatureOral ulceration and blistering in patients with COVID-19A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain\u2010like lesions: lights and shadows on the relationship with COVID\u201019 infectionChilblains in children in the setting of COVID\u201019 pandemicDermatological diseases presented before COVID\u201019: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID\u201019?The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countriesClustered Cases of Acral Perniosis: Clinical Features, Histopathology and Relationship to COVID\u201019Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countriesReply to \u201cClinical and histological characterization of vesicular COVID\u201019 rashes: a prospective study in a tertiary care hospital\u201d: Pseudoherpetic Grover disease seems to appear in patients with COVID\u201019 infectionDermatologic manifestations and complications of COVID-19Clinical and histological characterization of vesicular COVID\u201019 rashes: A prospective study in a tertiary care hospitalErythema multiforme\u2010like lesions in children and COVID\u201019Cutaneous manifestations of the Coronavirus Disease 2019 (COVID\u201019): A brief reviewCutaneous signs in COVID\u201019 patients: A reviewSARS\u2010CoV\u20102 endothelial infection causes COVID\u201019 chilblains: histopathological, immunohistochemical and ultraestructural study of 7 paediatric casesErythema multiforme\u2010like eruption in patients with COVID\u201019 infection: clinical and histological findingsClassification of the cutaneous manifestations of COVID\u201019: a rapid prospective nationwide consensus study in Spain with 375 casesHistology of skin lesions establishes that the vesicular rash associated with COVID\u201019 is not \u201cvaricella\u2010like\u201dCutaneous manifestations in patients with COVID\u201019: A preliminary review of an emerging issueOral vesiculobullous lesions associated with SARS\u2010CoV\u20102 infectionAre chilblain\u2010like acral skin lesions really indicative of COVID\u201019?Cutaneous manifestations in hospitalized patients diagnosed as COVID-19.Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature.Follow-up of skin lesions during the evolution of COVID-19: a case report.Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.", "title_abstract_phrases": "Majority of lesions were localized on the trunk (66.7%, 50/72), however, 19.4% (14/72) of patients experienced cutaneous manifestations in the hands and feet.Although larger prospective studies are needed, current evidence indicates that acral skin lesions should not be regarded as a sign of COVID\u201019 in otherwise asymptomatic patients.A prospective study and literature reviewRecently, young COVID\u201019 patients have presented with erythematous and purpuric acral lesions similar to chilblains(1\u20133).The first report of cutaneous manifestations described different forms of skin lesions such as erythematous rash, urticaria and chicken\u2010pox\u2010like vesicles.2 Further studies have classified 5 different type of skin lesions, and associated them with patient demographics, timing in relation to symptoms of the disease, severity and prognosis.To establish the real prevalence of COVID\u201019 in patients with acral skin lesions, we firstly evaluated all the cases of acral lesions presented in dermatology and paediatrics departments and family doctors\u2019 offices in an eastern Spanish region over a three\u2010week period."}